A Multi-Center Study Evaluating the Safety of AC-170 0.24%

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
The purpose of this study is to evaluate the safety of AC-170 0.24% used twice daily in Healthy Adult Subjects and in Pediatric subjects with a history or family history of atopic disease (including allergic conjunctivitis).
Epistemonikos ID: a83214bb73763aab1276c9aa345d255cec5ca1fe
First added on: May 11, 2024